MedTrace Logo

ADHD, Gut Problems and Synbiotic

NCT07717359 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 174

Last updated 2026-07-21

No results posted yet for this study

Summary

The scope of this study is to evaluate the impact of a synbiotic product (a combination of probiotic bacteria and prebiotics) on symptoms reported by participants with ADHD. The main focus is to study the efficacy of the synbiotic product as compared to a placebo in improving emotion regulation and gut-health associated symptoms in adults with ADHD.

Conditions

  • ADHD
  • Gastrointestinal
  • Emotion Regulation Abilities

Interventions

DIETARY_SUPPLEMENT

Synbiotic Cap Gut-Brain

Capsules (2 capsules to be ingested once daily during 12 weeks)

OTHER

Placebo

Capsules (2 capsules to be ingested once daily during 12 weeks)

Sponsors & Collaborators

  • Super Synbiotics AB

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-30
Primary Completion
2027-10-31
Completion
2027-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07717359 on ClinicalTrials.gov